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Abstract
Background: Mycobacterium bovis, the causative agent of bovine tuberculosis, is a major cause of mortality in global cattle
populations. Macrophages are among the first cell types to encounter M. bovis following exposure and the response elicited
by these cells is pivotal in determining the outcome of infection. Here, a functional genomics approach was undertaken to
investigate global gene expression profiles in bovine monocyte-derived macrophages (MDM) purified from seven age-
matched non-related females, in response to in vitro challenge with M. bovis (multiplicity of infection 2:1). Total cellular RNA
was extracted from non-challenged control and M. bovis-challenged MDM for all animals at intervals of 2 hours, 6 hours and
24 hours post-challenge and prepared for global gene expression analysis using the AffymetrixH GeneChipH Bovine
Genome Array.
Results: Comparison of M. bovis-challenged MDM gene expression profiles with those from the non-challenged MDM
controls at each time point identified 3,064 differentially expressed genes 2 hours post-challenge, with 4,451 and 5,267
differentially expressed genes detected at the 6 hour and 24 hour time points, respectively (adjusted P-value threshold
#0.05). Notably, the number of downregulated genes exceeded the number of upregulated genes in the M. bovis-
challenged MDM across all time points; however, the fold-change in expression for the upregulated genes was markedly
higher than that for the downregulated genes. Systems analysis revealed enrichment for genes involved in: (1) the
inflammatory response; (2) cell signalling pathways, including Toll-like receptors and intracellular pathogen recognition
receptors; and (3) apoptosis.
Conclusions: The increased number of downregulated genes is consistent with previous studies showing that M. bovis
infection is associated with the repression of host gene expression. The results also support roles for MyD88-independent
signalling and intracellular PRRs in mediating the host response to M. bovis.
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Introduction
Bovine tuberculosis (BTB), an infectious disease caused by the
intracellular pathogen Mycobacterium bovis, continues to impact the
welfare of domestic herds, despite the implementation of
surveillance and control programmes in many countries. The
aetiology and host immune response to M. bovis infection is similar
to M. tuberculosis infection in humans [1,2]. M. bovis is transmitted
primarily via aerosolised respiratory secretions containing infec-
tious bacilli, with the natural site of infection being the respiratory
tract. Following initial exposure, the pathogen is encountered by
host alveolar macrophages, which serve as key effector cells in
activating the innate and adaptive immune responses required to
determine the outcome of infection [3].
Macrophage recognition of mycobacteria occurs through the
interaction of mycobacterial pathogen-associated molecular pat-
terns (PAMPs) with host pathogen recognition receptors (PRRs),
such as the Toll-like receptors (TLRs), expressed on the
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pathways resulting in the production of endogenous NF-kB-
inducible cytokines that promote an adaptive immune response
characterised by the release of proinflammatory interferon-
gamma (IFN-c) from T cells and natural killer (NK) cells [5,6].
In turn, IFN-c induces microbicidal activity in infected
macrophages and enhances the expression of major histocom-
patibility complex (MHC) class I and II molecules necessary for
the presentation of mycobacterial antigens on the macrophage
surface to T cells [4,5].
These molecular mechanisms culminate in the formation of
granulomas_organised complexes of immune cells comprised of
lymphocytes, non-infected macrophages and neutrophils that
contain mycobacterial-infected macrophages and prevent the
dissemination of bacilli to other organs and tissues_however, in
most cases the pathogen is not eliminated by the host [4]. The
survival of mycobacteria in host macrophages (within granulomas)
is believed to be achieved through a diverse range of molecular
mechanisms that subvert the host immune response. These include
the prevention of host phagosome maturation, the inhibition of
apoptosis in infected macrophages and the suppression of innate
cell signalling pathways and cytokine production necessary to
activate adaptive immune responses [7–9].
This persistence of mycobacteria can result in progression to
active tuberculosis, particularly in cases where the immune
response to infection is compromised [2,4]. Furthermore, it has
been proposed that mycobacteria can exploit several host defence
mechanisms, such as cytokine-induced necrosis, resulting in
immune pathology, dissemination of infection through the host
and ultimately shedding of the pathogen from the host, thus
maintaining the cycle of infection [10,11]. Consequently, analysis
of the macrophage transcriptome in response to mycobacterial
infection may provide insight into the cellular mechanisms
governing mycobacteria-macrophage interactions, enabling fur-
ther understanding of how modulation of these pathways can
result in pathology. In addition, identification of transcriptional
markers of infection may lead to the development of novel
diagnostics for BTB, providing new molecular tools for disease
control and eradication [12].
The recent availability of a complete Bos taurus genome [13],
coupled with the continuing development of high-throughput
genomic technologies, have enabled analysis of the transcriptional
changes induced in bovine macrophages following challenge with
M. bovis in vitro [14,15]. In the current study, purified monocyte-
derived macrophages (MDM) from seven age-matched unrelated
Holstein-Friesian females were used for in vitro challenge
experiments with cultured M. bovis (multiplicity of infection
[MOI] 2:1). Total cellular RNA was extracted from challenged
and non-challenged control MDM samples at intervals of 0 hours
(i.e. pre-infection) and 2 hours, 6 hours and 24 hours post-
challenge and prepared for global gene expression analyses using
the high-density AffymetrixH GeneChipH Bovine Genome Array.
This microarray contains 24,072 probe sets representing over
23,000 gene transcripts. Differentially expressed genes, identified
through comparison of the gene expression profiles from the M.
bovis-challenged MDM and the non-challenged control MDM at
the 2 hour, 6 hour and 24 hour time points, were subsequently
analysed with the IngenuityH Pathway Analysis Knowledge Base
(http://www.ingenuity.com) and used to reconstruct the macro-
phage cellular pathways underlying M. bovis infection. These data
add a novel layer of information regarding the complex
macrophage-specific molecular pathways elicited upon phagocy-
tosis of M. bovis and the role these pathways play in establishing the
host immune response to BTB.
Materials and Methods
Ethics statement
All animal procedures were carried out according to the
provisions of the Irish Cruelty to Animals Act (Department of
Health and Children licence number B100/3939) and ethical
approval for the study was obtained from the UCD Animal Ethics
Committee (protocol number AREC-P-07-25-MacHugh).
Animals
Seven age-matched (three-year old) unrelated Holstein-Friesian
females were used in this study. All animals were maintained
under uniform housing conditions and nutritional regimens at the
UCD Lyons Research Farm (Newcastle, County Kildare, Ireland).
The animals were selected from an experimental herd without a
recent history of bovine tuberculosis infection and all animals
tested negative for the single intradermal tuberculin test (SICTT).
These cattle were also negative for infection with Brucella abortus,
M. avium subsp. paratuberculosis, Salmonella Typhimurium, bovine
herpesvirus 1 (BHV-1) and bovine viral diarrhoea (BVD) virus.
Monocyte extraction and culture of bovine MDM
For monocyte isolation, 300 ml of whole blood was collected in
acid citrate dextrose buffer (Sigma-Aldrich Ireland Ltd., Dublin,
Ireland) in sterile bottles. Blood was layered onto Accuspin
TM
tubes containing HistopaqueH 1077 (Sigma-Aldrich Ireland Ltd.,
Dublin, Ireland), and following density gradient centrifugation
(500 g for 20 minutes) performed at room temperature, peripheral
blood mononuclear cells (PBMC) were collected. Contaminating
red blood cells (RBC) were removed following resuspension and
subsequent incubation of the PBMC in RBC lysis buffer (10 mM
KHCO3, 150 mM NH4Cl, 0.1 mM EDTA pH 8.0) for 5 minutes
at room temperature. After incubation, PBMC were washed twice
with sterile phosphate-buffered saline (PBS; Invitrogen
TM, Life
Technologies Corporation, Paisley, UK) before resuspending cells
in PBS containing 1% bovine serum albumin (BSA; Sigma-Aldrich
Ireland Ltd., Dublin, Ireland). Monocytes were then isolated using
the MACSH protocol and MACSH MicroBeads conjugated to
mouse anti-human CD14 antibodies (Miltenyi Biotec Ltd., Surrey,
UK), which has been shown to be cross-reactive with bovine
monocytes [16]. The MACSH protocol was performed according
to the manufacturers’ instructions.
The identity and purity of monocytes was confirmed by flow
cytometry using an anti-CD14 fluorescein-labelled antibody (data
not shown). This method has been previously shown by us to yield
a purity of CD14
+ cells $99% [17]. Purified monocytes were
seeded at 1610
6 per well on 24-well tissue culture plates in RPMI
1640 medium (Invitrogen
TM, Life Technologies Corporation,
Paisley, UK) containing 15% heat inactivated foetal calf serum
(FCS; Sigma-Aldrich Ireland Ltd., Dublin, Ireland), 1% non-
essential amino acids (NEAA; Sigma-Aldrich Ireland Ltd., Dublin,
Ireland), gentamicin (5 mg/ml; Sigma-Aldrich Ireland Ltd.,
Dublin, Ireland) and incubated at 37uC, 5% CO2. Following
24 hours incubation (day one) the media was replaced with 1 ml
fresh antibiotic-containing media to remove any non-adhered
cells. On day three, media was replaced with 1 ml antibiotic-free
culture media (RPMI 1640 medium containing 15% heat
inactivated FCS and 1% NEAA only). To ensure that the same
number of MDM were subjected to M. bovis-challenge, cells were
dissociated on day five using 16 non-enzymatic cell dissociation
solution (Sigma-Aldrich Ireland Ltd., Dublin, Ireland), counted
and then re-seeded at 2610
5 cells per well in 24-well tissue culture
plates (Sarstedt Ltd., County Wexford, Ireland) using antibiotic-
free culture media. By day eight, 80–100% confluent monolayers
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macrophage morphology as confirmed by Giemsa staining (data
not shown). On day eight, MDM were used for the in vitro
challenge experiments with M. bovis.
Culture of M. bovis
The M. bovis M2137 strain was used in this study. This strain is a
clinical isolate from a tuberculous badger, isolated in 2001. The
strain bears the SB0142 spoligotype, a strain type frequently
isolated from badgers and cattle in Ireland. This isolate of M. bovis
was supplied by Mr. Eamon Costello (Irish Department of
Agriculture, Food and the Marine, Backweston Laboratory
Campus, Celbridge, Co. Kildare).
Culturing of M. bovis was performed in a Biosafety Containment
Level 3 (CL3) laboratory and conformed to the national guidelines
on the use of Hazard Group 3 infectious organisms. M. bovis stocks
for the in vitro MDM-challenge experiments were cultured in
Middlebrook 7H9 medium (Difco
TM, Becton, Dickinson Ltd.,
Oxford, UK) containing 10% (volume/volume) Middlebrook
albumin-dextrose-catalase (ADC) enrichment (Difco
TM, Becton,
Dickinson Ltd., Oxford, UK), 0.05% Tween 80 (Sigma-Aldrich,
Dublin, Ireland) and 0.40% (weight/volume) sodium pyruvate
(Sigma-Aldrich Ltd., Dublin, Ireland) at 37uC. Bacterial cultures
were grown to mid-logarithmic phase as determined by spectro-
photometric analysis prior to the challenge experiments using the
purified bovine MDM. Colony-forming unit (cfu) counting was
performed using Middlebrook 7H11 medium (Difco
TM, Becton-
Dickinson Ltd., Dublin, Ireland) containing 0.40% (volume/
volume) sodium pyruvate (Sigma-Aldrich, Dublin, Ireland) and
10% (volume/volume) Middlebrook (ADC) enrichment (Difco
TM,
Becton-Dickinson Ltd., Dublin, Ireland).
In vitro challenge of bovine MDM with M. bovis and RNA
extraction
A schematic outlining the experimental design used in the
current study is depicted in Figure 1. All in vitro challenge
experiments including the preparation of non-challenge control
MDM samples were performed in the CL3 laboratory. Prior to the
M. bovis challenge experiments, MDM from two adjacent culture
plate wells were lysed using RLT buffer from the RNeasy Mini kit
(Qiagen Ltd., Crawley, UK) supplemented with 1% b-mercapto-
ethanol (Sigma-Aldrich Ireland Ltd., Dublin, Ireland) and pooled.
These samples constituted the 0 hour control MDM.
MDM (seeded at 2610
5 cells per well) were challenged with M.
bovis (4610
5 cells per well) prepared in antibiotic-free culture
media (RPMI 1640 medium containing 15% heat inactivated FCS
and 1% NEAA only). M. bovis cell counts were performed using a
Petroff Hausser chamber (Fisher Scientific Ltd., Dublin, Ireland)
following sterile filtering to prevent clumping using a 5 micron
filter (Millipore Ireland Ltd., County Cork, Ireland). M. bovis cell
numbers were then adjusted and 4610
5 cells were added to the
appropriate wells giving an MOI of 2:1. Subsequent cfu counting
also yielded a mean MOI of 2:1. Once challenged, MDM were
then incubated at 37uC, 5% CO2 for 2 hours, 6 hours and
24 hours. For the non-challenged control samples at each time-
point, antibiotic-free culture media (RPMI 1640 medium
Figure 1. Schematic depicting the experimental design used in the current study. MDM were cultured in 24-well tissue culture plates
(2610
5 cells per well) and challenged with M. bovis (MOI 2:1). RNA was extracted from M.bovis-challenged and non-challenged control MDM at three
time points post-challenge: 2 hours, 6 hours and 24 hours. In addition, RNA was extracted from a 0 hour non-challenged control to assess potential
non-experimental changes in gene expression. The MDM lysates from replicate tissue culture wells (shaded) were pooled for RNA extraction. Global
gene expression for the control and M. bovis-challenged MDM was analysed using the AffymetrixH GeneChipH Bovine Genome Array.
doi:10.1371/journal.pone.0032034.g001
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added to each well. After 2 hours post-challenge, the media from
all 6 hour and 24 hour challenge experiments was replaced with
0.5 ml fresh antibiotic-free culture media per well and re-
incubated at 37uC, 5% CO2 until MDM were required for
harvesting. Challenged and non-challenged control MDM were
lysed and harvested using RLT-1% b-mercaptoethanol buffer
(Qiagen Ltd., Crawley, UK) at the designated time points. For
each treatment, MDM lysates from two culture plate wells were
pooled and stored at 280uC until required for RNA extraction.
RNA extraction and microarray analysis
All RNA extractions were performed in the CL3 laboratory
using an RNeasy kit incorporating an on-column DNase treatment
step (Qiagen Ltd., Crawley, UK) according to the manufacturer’s
instructions. RNA quantity and quality was assessed using a
NanoDrop
TM 1000 spectrophotometer (Thermo Fisher Scientific
Inc., Waltham, MA, USA) and on an Agilent 2100 Bioanalyzer
using an RNA 6000 Nano LabChip kit (Agilent Technologies Ltd.,
Cork, Ireland). All samples displayed a 260/280 ratio greater than
2.0 and RNA integrity numbers (RIN) greater than 8.5.
Total cellular RNA extracted from non-challenged control and
M. bovis-challenged MDM from all seven animals at the 0 hour,
2 hour, 6 hour and 24 hour time points (giving a total of 49
samples) was prepared for global gene expression analyses using
the pan-genomic high-density AffymetrixH GeneChipH Bovine
Genome Array (Affymetrix UK Ltd., High Wycombe, UK;
http://www.affymetrix.com). This array contains 24,072 probe
sets representing over 23,000 gene transcript and includes
approximately 19,000 UniGene clusters. cDNA labelling, hybrid-
isation and scanning for the microarray experiments were
performed by Almac Diagnostics Ltd. (Craigavon, Co. Armagh,
Northern Ireland) using a one-cycle amplification/labelling
protocol.
Statistical analysis of microarray data
AffymetrixH GeneChipH Bovine Genome Array data were
analysed using the BioConductor software project [18] (http://
www.bioconductor.org) contained within the R statistical environ-
ment (http://www.r-project.org). Quality control analysis was
performed on all 49 microarrays using the Simpleaffy software
package [19] contained within BioConductor. Normalisation of
raw data was performed using the Factor Analysis for Robust
Microarray Summarization (FARMS) algorithm. The FARMS
algorithm uses only perfect match probes and a quantile
normalization procedure, providing both P-values and signal
intensities [20]. Normalised data were then further subjected to
filtering for informative probe sets using the Informative/Non-
informative calls (I/NI-calls) software package within R [21]. I/
NI-calls uses multiple probes for the same gene as repeated
measures to quantify the signal-to-noise ratio of that specific probe
set. Principal component analysis (PCA) was performed using data
from all informative probe sets following all data filtering steps
from the M. bovis-challenged and non-challenged control samples
at the 2, 6 and 24 hour time points. The MultiExperiment Viewer
version 4.7 software package [22] was used for PCA with
Euclidean distance as the distance metric.
Differentially expressed genes were identified using the Linear
Models for Microarray Data (LIMMA) package [23] contained
within R. Genes displaying differential expression patterns
between non-challenged control and M. bovis-challenged MDM
at the 2, 6 and 24 hour time points were annotated using the
AffymetrixH bovine gene annotation (http://www.affymetrix.
com). The Benjamini-Hochberg multiple testing correction
method [24] was applied to all differentially expressed genes to
minimise the false discovery rate (FDR) and adjusted P-values for
differentially expressed genes were calculated (adjusted P-value
threshold 0.05).
Geometric mean fold-changes in gene expression are presented
in the current study following back-transformation of mean log2
fold-changes obtained from statistical analysis of microarray data.
For replicate probes for single genes, the average log2 expression
fold-change was used and subsequently back-transformed. The
negative reciprocals of the geometric fold-changes were calculated
and are presented for downregulated genes. All microarray data
were MIAME compliant [25] and have been submitted to the
NCBI Gene Expression Omnibus (GEO) database [26] with
experiment series accession number GSE33309.
Systems biology analyses
IngenuityH Systems Pathway Analysis (IPA; Ingenuity Systems,
Redwood City, CA, USA; http://www.ingenuity.com) was used to
identify canonical pathways and functional processes of biological
importance within the list of differentially expressed genes. The
IngenuityH Knowledge Base contains the largest database of
manually-curated and experimentally-validated physical, tran-
scriptional and enzymatic molecular interactions. Furthermore,
each interaction in the IngenuityH Knowledge Base is supported
by previously published information.
For IPA analysis, the AffymetrixH GeneChipH Bovine Genome
Array was used as a reference gene set. All differentially expressed
genes with an adjusted P value#0.05 were included in the
uploaded gene list and only differentially expressed genes mapping
to molecules in the IngenuityH Knowledge Base were used for
systems analysis. Functional analysis of genes was performed using
IPA to characterise the biological functions of the differentially
expressed genes between the control and M. bovis-challenged
MDM. For this, IPA performed an over-representation analysis
that categorises the differentially expressed genes within the
uploaded list into functional gene ontology (GO) categories. Each
GO category in IPA is ranked based on the number of
differentially expressed genes falling into each functional group.
Right-tailed Fisher’s exact tests were used to calculate a P-value for
each of the biological functions assigned to the list of differentially
expressed genes.
IPA contains a large library of known canonical pathways that
were overlaid with the differentially expressed genes to identify
major biological pathways associated with M. bovis infection in
MDM. The significance of the association between differentially
expressed genes and the canonical pathway was assessed using two
methods: (1) a ratio of the number of molecules from the
differentially expressed gene data set that map to the pathway,
compared to the total number of molecules that map to the
canonical pathway based on the reference gene list; and (2) a
Fisher’s exact test that generates a P-value for the assignment of
the differentially expressed genes to a particular canonical pathway
compared to the reference gene list. Canonical pathways were
then overlaid with the expression values of the differentially
expressed genes.
Conventional cDNA preparation for real time quantitative
reverse transcription PCR (qRT-PCR) analysis
cDNA was prepared from 80 ng of total RNA isolated from
each sample analysed in the microarray study (including the
0 hour control RNA samples) using a High Capacity cDNA
Reverse Transcription Kit (Applied BiosystemsH, Life Technolo-
gies Corporation, Warrington, UK). cDNA conversions were
performed in 20 ml reaction volumes using random primers as per
Bovine Macrophage Response to M. bovis
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(comprising ,10 RNA samples per pool) was included in non-
reverse transcriptase (non-RT) control reactions to test for the
presence of contaminating genomic DNA during real-time qRT-
PCR analysis. All cDNA samples and non-RT controls were
diluted 1:8 (final concentration cDNA 0.5 ng/ml) using RNAse-
and DNAse-free water and stored at 220uC prior to real time
qRT-PCR analysis.
Whole-transcriptome amplified cDNA preparation for real
time quantitative reverse transcription PCR (qRT-PCR)
analysis
To generate a repository of cDNA from each RNA sample,
whole-transcriptome linearly amplified cDNA was prepared using
the WT-Ovation
TM RNA Amplification System (NuGEN Tech-
nologies Inc., Bemmel, the Netherlands). For this, 25 ng of
template RNA was included in each amplification reaction (40 ml
final volume) and all procedures were performed according to the
manufacturer’s instructions. In addition, non-template controls
that included RNAse- and DNAse-free water instead of RNA
template were also prepared using the WT-Ovation
TM RNA
Amplification System kit. Once amplification reactions were
completed, the amplified cDNA and non-template controls were
diluted 1:1,000 using RNAse- and DNAse-free water and stored at
220uC prior to real time qRT-PCR analysis.
Real time quantitative reverse transcription PCR (qRT-
PCR) analysis and validation of microarray results
Intron-spanning primers were designed for each gene using the
Primer3Plus package [27] and commercially synthesised (Eurofins
MWG Operon, Ebersberg, Germany). Table S1 provides
sequence information for all primer pairs used. Real time qRT-
PCR reactions (20 ml final volume) were performed on 96-well
plates using Fast SYBRH Green Master Mix (Applied BiosystemsH,
Life Technologies Corporation, Warrington, UK) on a 7500 Fast
Real Time PCR System (Applied BiosystemsH, Life Technologies
Corporation, Warrington, UK) as per manufacturer’s instructions.
Real time qRT-PCR amplifications contained as template either:
(a) 2 ml of the diluted conventionally-prepared cDNA/non-RT
control (equivalent to 1.0 ng of total RNA); or (b) 2 ml of the
diluted linearly amplified cDNA/non-RNA template control. A
final concentration of 300 nM of each forward and reverse primer
was included in each amplification reaction. Non-template real
time qRT-PCR controls and a seven-point standard curve
prepared from 1:2 serial dilutions of pooled conventionally-
prepared cDNA or linearly amplified cDNA from each M. bovis-
challenged MDM sample were included on every real time qRT-
PCR plate.
PCR thermal cycling conditions for each amplicon comprised
one cycle at 50uC for 2 minutes, one cycle at 95uC for 20 seconds,
followed by 40 cycles at 95uC for 3 seconds and 60uC for
30 seconds. A dissociation step was included for all amplifications
to confirm the presence of single discrete PCR products of the
expected size; this was further confirmed by visualisation of the
amplification products on 2% agarose gels stained with 0.5 mg/ml
ethidium bromide (Invitrogen
TM, Life Technologies Corporation,
Paisley, UK).
Statistical analysis of real time qRT-PCR data
All real time qRT-PCR data, including primer efficiency
estimations using the standard curves, were analysed using the
qbase
PLUS software package [28] (Biogazelle NV, Zwijnaarde,
Belgium). Real time qRT-PCR efficiency correction and normal-
isation was performed using the peptidylprolyl isomerase A
(cyclophilin A) gene (PPIA) as a reference gene based on GeNorm
analysis performed by us in a previous study involving bovine
MDM [17]. PPIA expression profiles were generated for both the
conventionally-prepared and linearly amplified cDNA templates
for all samples to ensure appropriate real time qRT-PCR
efficiency correction and normalisation analyses were performed
for all genes-of-interest.
Calibrated normalised relative quantities (CNRQ) of gene
expression for each analysed sample, as generated by the
qbase
PLUS package, were used to calculate fold-changes in
expression for each gene. For this, the CNRQ value generated
for each M. bovis-challenged MDM sample was divided by the
CNRQ value generated for the non-challenged control MDM
sample at the corresponding post-challenge time point from the
same animal. Log2 fold-changes in gene expression were then used
for the statistical analysis of all genes analysed using real time
qRT-PCR. All statistical analyses were performed using the SPSS
statistical package (IBM Corporation, Armonk, NY, USA) and the
Minitab version 16 statistical package (Minitab Ltd., Coventry,
UK).
Anderson-Darling tests of normality were applied to the
residuals of the log2 fold-change values at each time point prior
to statistical analysis to ensure the data conformed to a normal
distribution—no significant departures from normality were
observed for any of the genes analysed (P$0.05). Two-tailed
paired Student’s t-tests were used to assess significant differences in
mean log2 fold-changes in gene expression between the M. bovis-
challenged MDM and the non-challenged control MDM at each
time point post-challenge. Geometric mean fold-changes in
expression were generated for each gene by back-transformation
of the log2 fold-change data. The negative reciprocals of the
geometric fold-changes were calculated and are presented for
downregulated genes.
To validate the performance of the linearly amplified cDNA in
real time qRT-PCR amplifications, the expression profiles of four
genes (CCL5, CCL20, IL1B and IL6) were generated using both
conventionally-prepared cDNA and linearly amplified cDNA. The
log2 fold-changes in gene expression in the M. bovis-challenged
MDM (relative to the control MDM) were then compared for both
template types using regression analysis.
Results
A summary of differential gene expression at each time
point post-challenge with M. bovis
In total, 12,339 probe sets on the microarray passed filtering for
informative probe sets using the I/NI-calls R package. PCA was
performed using all informative transcripts that passed the data
filtering process for all samples at the 2, 6 and 24 hour time points
(Figure 2). Principal component 1 (PC1) primarily separates the
challenge status (i.e. M. bovis-challenged and non-challenged
controls) of the MDM samples, while PC2 delineates the M.
bovis-challenged MDM with respect to time post-challenge. PC1
and PC2 account for 23.31% and 17.05% of the total variation in
gene expression, respectively.
The gene expression data were then used to compare the gene
expression profiles between the M. bovis-challenged MDM and
non-challenged MDM samples across all time points, the results of
which are summarised in Figure 3. This shows that the number of
differentially expressed genes increased with each time point post-
challenge, with the highest number of differentially expressed
genes identified at the 24 hour time point. Furthermore, the
number of downregulated genes exceeded the number of
Bovine Macrophage Response to M. bovis
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challenged MDM at each time point.
Analysis of global gene expression after 2 hours post-
challenge with M. bovis
At 2 hours post-challenge, a total of 3,529 transcripts,
representing 3,064 unique genes, were identified as being
differentially expressed between the M. bovis-challenged and non-
challenged MDM (adjusted P-value#0.05). Of these, 1,253
transcripts (representing 1,031 genes) were upregulated while the
remaining 2,276 transcripts (representing 2,033 genes) were
downregulated in the M. bovis-challenged MDM. Notably, the
relative fold-change in expression was markedly higher for the
upregulated genes compared to the downregulated genes at this
time point. A complete list of the differentially expressed genes and
the relative fold-change in expression at the 2 hour time point
post-challenge are provided in Table S2.
Further inspection of the differentially expressed genes revealed
that many of the highly upregulated genes at this time point had
immune-related functions. These included NF-kB-inducible chemo-
kine and cytokine genes, such as the (C-C motif) ligand 20 gene
(CCL20); the interleukin 1, beta gene (IL1B); the chemokine (C-X-C
motif)ligand2 gene (CXCL2);the interleukin1,alphagene (IL1A); the
tumour necrosis factor gene (TNF) and the interleukin 6 gene (IL6).
Figure 2. Principal component analysis for all individual control and M. bovis-challenged MDM at the 2 hour, 6 hour and 24 hour
time points. Principal component (PC) 1 and PC2 are shown (accounting for 23.31% and 17.05% of the total variation, respectively). PCA was
performed using data for all genes whose probes passed the data filtering process with Euclidean distance as the distance metric.
doi:10.1371/journal.pone.0032034.g002
Figure 3. The number of significantly differentially expressed genes at each time point post-M. bovis challenge. The number of
upregulated and downregulated genes in the M. bovis-challenged MDM relative to the control MDM at each time point are shown (adjusted P-value
0.05).
doi:10.1371/journal.pone.0032034.g003
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were also differentially expressed 2 hours post-M. bovis challenge.
These included TLR2 (upregulated); the myeloid differentiation
primary response (88) gene (MYD88) [downregulated]; the
interleukin-1 receptor-associated kinase 1 gene (IRAK1) [downreg-
ulated]; the interleukin-1 receptor-associated kinase 4 gene
(IRAK4) [downregulated]; the toll-like receptor adaptor molecule
1 gene (TICAM1) [upregulated; note: this gene was not present on
the microarray but was analysed using real time qRT-PCR]; the
TNF receptor-associated factor 6 gene (TRAF6) [upregulated]; the
TNF receptor-associated factor 3 gene (TRAF3) [upregulated]; the
TGF-beta activated kinase 1/MAP3K7 binding protein 2 gene
(TAB2) [upregulated] and the nuclear factor of kappa light
polypeptide gene enhancer in B-cells inhibitor, alpha gene
(NFKBIA) [upregulated]. The genes encoding NF-kB1 (NFKB1)
and NF-kB2 (NFKB2) were also upregulated in the M. bovis-
challenged MDM at this time point (Figure 4). TLR4 and the gene
encoding IFN-c (IFNG)_two genes previously reported to play an
important role in the immune response to mycobacterial infection
[4]_were not differentially expressed at the 2 hour time point.
Of the 3,064 differentially expressed genes identified at 2 hours
post-challenge, 1,916 mapped to unique molecules represented in
the IngenuityH Knowledge Base. Functional categorisation
analysis using IPA showed that the differentially expressed genes
had roles involved in the regulation of gene transcription, the
immune response and cell signalling (Table S3). IPA was also used
to identify the top ranking canonical pathways enriched for
differentially expressed genes in response to M. bovis challenge.
Figure 4. Differential gene expression in the TLR signalling pathway 2 hours post-M. bovis challenge. Genes within the TLR signalling
pathway showing differential expression are highlighted in colour. Colour intensity indicates the degree of upregulation (red) or downregulation
relative to the control MDM. Grey shading indicates genes that were not differentially expressed; white shading represents genes in the pathway not
represented on the microarray; mycobacterial PAMPs are shaded orange.
doi:10.1371/journal.pone.0032034.g004
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immunological role and included Interleukin 10 signalling (1
st ranked
pathway), B cell activating factor signalling (2
nd ranked pathway), CD40
signalling (4
th ranked pathway) and IL6 signalling (5
th ranked
pathway) (Table S4).
Analysis of global gene expression after 6 hours post-
challenge with M. bovis
Comparison of the M. bovis-challenged MDM and non-
challenged control MDM 6 hour post-challenge, revealed 5,211
differentially expressed transcripts, comprising 4,451 differentially
expressed genes. Of these, 2,458 transcripts (representing 2,027
unique genes) were upregulated and 2,753 transcripts (represent-
ing 2,424 unique genes) were downregulated in the M. bovis-
challenged MDM (Table S5). As with the 2 hour time point, the
relative fold-change in expression was markedly higher for the
upregulated genes compared to the downregulated genes after
6 hours post-challenge.
Immune-related genes were among the differentially expressed
genes showing the highest relative increase in expression. The
identity of the genes displaying the highest fold-change in
expression at the 6 hour time point were similar to those detected
at the 2 hour time point, among which were CCL20, IL1B, TNF
and IL6. IFNG was also upregulated in the M. bovis-challenged
MDM at this time point. In addition, a small number of genes
encoding proteins belonging to TLR signalling pathways displayed
differential expression in the M. bovis-challenged MDM, included
TLR3 (upregulated), IRAK1 (downregulated), IRAK4 (downregu-
lated), TICAM2 (upregulated) and TRAF3 (upregulated). The
genes encoding TLR2, TLR4, MyD88, TICAM1 and TRAF6
were not differentially expressed at this time point.
Of the 4,451 differentially expressed genes identified at 6 hours
post-challenge, 2,850 mapped to unique molecules represented in
the IngenuityH Knowledge Base. Functional analysis comparing
M. bovis-challenged and non-challenged MDM transcriptomes
revealed an enrichment of genes with immunological, apoptotic
and cellular signalling functions (Table S6). Cellular pathways
associated with the immune response were also among the top
ranking canonical pathways identified by IPA, several of which
were similar to those identified at the 2 hour time point. These
included IL6 signalling (5
th ranked pathway), CD40 signalling (8
th
ranked pathway) and IL10 signalling (11
th ranked pathway).
Death receptor signalling was identified as the fourth highest ranking
canonical pathway 6 hours post M. bovis-challenge. Given the
previously identified role of programmed cell death during
mycobacterial infection in vitro [14,15], the pattern of differential
gene expression in this pathway is depicted in Figure 5.
Interestingly, the Role of retinoic-acid-inducible I (RIGI)-like receptors
in anti-viral innate immunity (14
th ranked pathway), a cellular pathway
primarily involved in the host recognition of viral PAMPs was also
listed among the top ranking canonical pathways after 6 hours
post-challenge with M. bovis (Table S7).
Figure 5. Differential gene expression associated with apoptosis 6 hours post-M. bovis challenge. Genes associated with apoptosis
showing differential expression are highlighted in colour. Colour intensity indicates the degree of upregulation (red) or downregulation relativet o
the control MDM. Grey shading indicates genes that were not differentially expressed; white shading represents genes in the pathway not
represented on the microarray.
doi:10.1371/journal.pone.0032034.g005
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post-challenge with M. bovis
6,150 differentially expressed transcripts representing 5,267
unique genes were identified through comparison of the global
gene expression profiles of the M. bovis-challenged MDM and the
non-challenged control MDM 24 hours post-challenge (Table S8).
Of these, 2,537 transcripts (comprising 2,093 unique genes) were
upregulated and 3,613 transcripts (comprising 3,174 unique genes)
were downregulated in the M. bovis-challenged MDM. Among the
genes with immunological functions displaying high levels of
increased relative gene expression in the M. bovis-challenged
MDM included the chemokine (C-C motif) ligand 8 gene (CCL8),
the chemokine (C-X-C motif) ligand 11 gene (CXCL11), IL1B and
IL6. TNF and IFNG also displayed increased relative expression in
the M. bovis-challenged MDM at this time point.
Of the 5,267 differentially expressed genes identified at
24 hours post-challenge, 3,377 mapped to unique molecules
represented in the IngenuityH Knowledge Base. As with the
2 hour and 6 hour time points, functional categorisation of the
differentially expressed genes 24 hours post-challenge revealed an
enrichment of genes involved in the host immune response,
particularly the activation and development of the adaptive
immune response (Table S9). Furthermore, many of the top
ranking canonical cellular pathways identified 24 hours post-M.
bovis challenge were associated with adaptive immune function.
These included Communication between innate and adaptive immune cells
(3
rd ranked pathway); Interferon signalling (8
th ranked pathway); T
helper cell differentiation (9
th ranked pathway) and IL6 signalling (12
th
ranked pathway) (Table S10).
As with the 6 hour post-challenge results, systems analysis also
identified intracellular PRRs as playing a role in M. bovis infection
in vitro. This was evidenced by the identification of Activation of
interferon regulatory factors by cytosolic pattern recognition receptors (5
th
ranked pathway, presented in Figure 6) and the Role of RIG-I-like
receptors in antiviral innate immunity (7
th ranked pathway) among the
top ranking canonical pathways at the 24 hour time point.
Real time quantitative reverse transcription PCR (qRT-
PCR) analysis and validation of microarray results
A panel of the 16 top ranking differentially expressed genes
identified through analysis of the microarray data were selected for
real time qRT-PCR analysis and validation. Selection of these
genes was based largely on the highest fold-change in increased
and reduced relative expression and the lowest adjusted P-value
across all three time points. These genes were: AREGB, CCL4,
CCL5, CCL20, CD40, CFB, CXCL2, FOS, IL1B, IL6, IL15, IRF1,
NFKB2, PIK3IP1, SPRY2 and TNF. In addition, the expression
profile of TICAM1, which was not represented on the AffymetrixH
GeneChipH Bovine Genome Array, was analysed using real time
qRT-PCR.
Of the total of 17 genes analysed using real time qRT-PCR,
eight genes (CCL4, CD40, CFB, CXCL2, IL15, IRF1, NFKB2 and
TNF) were analysed using conventionally-prepared cDNA tem-
plate only; five genes (AREGB, FOS, PIK3IP1, SPRY and TICAM1)
were analysed using the linearly amplified cDNA template only;
while the remaining four genes (CCL5, CCL20, IL1B and IL6) were
analysed using both the conventionally-prepared cDNA and the
linearly amplified cDNA templates in order to validate the
performance of the linearly amplified cDNA in real time qRT-
PCR analyses.
To validate the performance of the linearly amplified cDNA in
real time qRT-PCR amplifications, the expression profiles
generated for the CCL5, CCL20, IL1B and IL6 genes using
conventionally-prepared and linearly amplified cDNA were
compared. For this, regression analysis was performed using the
log2 fold-changes in relative gene expression for the M. bovis-
challenged MDM analysed for the two different cDNA templates
across all three post-challenge time points, revealing a high
correlation for all four genes (r
2$0.65, P#0.001) (Figure S1).
Furthermore, the geometric mean fold-changes in expression and
Student’s t-test statistics in the M. bovis-challenged MDM relative
to the control MDM for these genes were similar across all three
time points (Figure S2 and Table S11). These results suggest that
no preferential amplification bias of gene transcripts or amplifi-
cation artefacts occurred during the preparation of the linearly
amplified cDNA. Consequently, we concluded that the use of the
linearly amplified cDNA was suitable in the current study.
The relative fold-changes in expression between the M. bovis-
challenged and control MDM for the IL1B, IL6, NFKB2 and TNF
genes as determined through real time qRT-PCR analysis (using
the conventionally-prepared cDNA as template) are depicted
graphically in Figure 7, while fold-changes in expression for all
other genes analysed are shown graphically in Figure S3. In
addition, comparisons between the results from the real time qRT-
PCR and microarray analyses for all genes are given in Table S12.
These results showed that twelve genes (CCL4, CCL5, CCL20,
CD40, CFB, CXCL2, IL1B, IL6, IL15, IRF1, NFKB2 and TNF) were
significantly upregulated across all three time points (P#0.01).
Two genes (AREGB and FOS) displayed significant downregulation
in the M. bovis-challenged MDM samples across all time points
(P#0.05). TICAM1 was differentially expressed (upregulated) only
at the 2 hour time point (P#0.001). PIK3IP1 showed significant
decreased relative expression in the M. bovis-challenged samples at
the 2 hour and 6 hour time points (P#0.05); however, this gene
was not differentially expressed at the 24 hour time point. SPRY2
displayed significant (P#0.05) decreased relative expression in the
M. bovis-challenged MDM at the 2 hour time point but was not
differentially expressed after 6 hours and 24 hours post-challenge.
Comparison of the real time qRT-PCR expression profiles of each
gene for the 2 hour, 6 hour and 24 hour non-challenged control
MDM relative to the 0 hour non-challenged control MDM did
not reveal significant differential expression (P$0.05) for 16 of the
17 analysed genes; only the expression profile of the AREGB gene
in the 0 hour control MDM differed from the control MDM at
2 hours and 6 hours (P#0.01).
Gene expression profiles for all 16 genes analysed using both
real time qRT-PCR and microarray platforms were largely the
same across all three time points. Only the expression profile of the
SPRY gene at 6 hours and 24 hours post-challenge and the
PIK3IP1 gene at 24 hours post-challenge did not display significant
differential expression (P$0.05) between the M. bovis-challenged
and non-challenged control MDM based on real time qRT-PCR
analysis but displayed significant reduced relative expression
(adjusted P-value threshold #0.05) based on the microarray
results at these time points. The observed discrepancies between
the microarray and real time qRT-PCR data for the SPRY2 and
PIK3IP1 genes at the 6 hour and 24 hour time points may reflect
differences in the sensitivity of the two analytical methods used
and/or differences in the mRNA transcripts targeted by the probes
(microarray) and primer pairs (real time qRT-PCR) used for the
two forms of gene expression analysis [29,30].
Discussion
The host immune response to mycobacterial infection is highly
complex and involves interaction between innate and adaptive
immune mechanisms. The macrophage is among the first innate
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elicited by these cells is key to the control of infection [3,31].
Consequently, investigation of gene transcriptional changes in
macrophages following mycobacterial challenge in vitro provides a
model for understanding the complex host-pathogen interactions
and innate cellular signalling pathways that underlie the host
immune response to mycobacterial infection. Therefore, for the
current study, we have investigated gene expression in bovine
MDM in response to M. bovis challenge in vitro using the pan-
genomic high-density AffymetrixH GeneChipH Bovine Genome
Array at 2, 6 and 24 hours post-challenge. The gene expression
data from these analyses were used to investigate and reconstruct
key host regulatory networks involved during early mycobacterial
infection.
It is important to note that MDM are not the primary cell type
that recognise M. bovis during the course of natural infection and
that bovine alveolar macrophages would be a more appropriate
cell type to analyse the host transcriptional response to M. bovis
challenge in vitro. However, MDM are widely used for in vitro
challenge experiments involving mycobacteria as they best mimic
the in situ status of infection compared to other cell types used for
experimental infection (e.g. cell lines), particularly in experiments
Figure 6. Differential gene expression associated with intracellular pathogen recognition receptors 24 hours post-M. bovis
challenge. Genes associated with intracellular PRR signalling showing differential expression are highlighted in colour. Colour intensity indicates the
degree of upregulation (red) or downregulation relative to the control MDM. Grey shading indicates genes that were not differentially expressed;
white shading represents genes in the pathway not represented on the microarray; viral PAMPs are shaded orange.
doi:10.1371/journal.pone.0032034.g006
Figure 7. Real time qRT-PCR analysis of the IL1B, IL6, NFKB2 and TNF genes following M. bovis challenge. Log2 fold-changes in expression
in the M. bovis-challenged MDM relative to the non-challenged control MDM at all three time points are shown. For comparison, the expression
profiles for these genes based on the microarray data are also shown. The significance of the fold-changes in expression for each gene based on the
real time qRT-PCR analysis only are denoted by asterisks in the figure (*P#0.05, **P#0.01, ***P#0.001). The fold-changes calculated for each gene
from the microarray data in the M. bovis-challenged MDM for each gene at each time point were significant (adjusted P-value # 0.05). In addition, the
log2 fold-change in expression for the control MDM at each time point relative to the 0 hour control MDM are also shown for both the microarray and
real time qRT-PCR data; no significant differences in gene expression between the control MDM relative to the 0 hour control was observed for these
genes at each time point (P$0.05).
doi:10.1371/journal.pone.0032034.g007
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Furthermore, bovine MDM are easily prepared from peripheral
blood mononuclear cells using standard procedures, whereas the
preparation of bovine alveolar macrophages requires post-mortem
lung lavages [14,39]. Finally, blood macrophages do recognise
mycobacteria during secondary phases of infection that occur
when bacilli disseminate from infected primary alveolar macro-
phages [40]; therefore, the results presented in the current study
may also provide insight into the macrophage immune mecha-
nisms that occur during the progression of infection.
It should also be noted that the culturing of M. bovis as
performed in this study involved the use of growth media
containing Tween 80, a non-ionic surface-active detergent that
affects the mycobacterial cell wall composition, causing a
reduction in virulence [41]. However, Tween 80 is routinely
added to liquid media to reduce cell clumping (which can affect
colony-forming unit [cfu] counts), therefore enabling homoge-
neous cell suspensions of mycobacteria to be obtained for in vitro
macrophage challenge experiments [41,42]. As such, the current
study is directly comparable to recent studies investigating the
interaction of M. tuberculosis complex bacilli with host macrophages
[14,32,33,43–45].
The patterns of global gene expression support the
association of M. bovis infection with repression of host
gene expression
Comparison of the gene expression profiles in the M. bovis-
challenged MDM relative to the control MDM at each time point
revealed an increase in the number of differentially expressed
genes across the three post-challenge time points analysed.
Notably, the number of downregulated genes exceeded the
number of upregulated genes at each time point; however, the
fold-change in expression for the upregulated genes was much
greater than that for the downregulated genes at each time point.
These findings support previous work by us and others showing
that mycobacterial infection in vitro and in vivo is associated with
pan-genomic and immuno-specific gene repression [46–49].
However, at each time point post-challenge, the mean fold-change
in expression for upregulated genes was markedly higher than the
mean fold-change in expression for downregulated genes.
Furthermore, many of the upregulated genes displaying the
highest fold-increase in expression at each time point post-
challenge had a known immunological role, while many of the
genes displaying the greatest reduction in expression had no
obvious immune function_a finding that highlights the complex
nature of the interaction between the macrophage and M. bovis
during infection.
Analysis of global gene expression signatures 2 hours
post-challenge with M. bovis support a role for MyD88-
independent signalling
Host innate immune recognition of mycobacterial pathogens is
largely regulated through the engagement of macrophage PRRs
with mycobacterial PAMPs. TLRs are among the most important
PRRs for the recognition of mycobacterial PAMPs during the
early stages of infection, particularly the cell surface TLR2 (acting
alone or as a heterodimeric complex with TLR1 or TLR6) and
TLR4 receptors [4,50]. More recently, membrane-associated
cytosolic TLRs, such as TLR8 and TLR9, and the cell surface
TLR5 receptor have also been shown to play a role in host
detection of mycobacteria [51-53].
TLR2 and TLR4 signalling is predominantly mediated through
the adaptor protein, MyD88, the activation of which results in the
initiation of an inflammatory signalling cascade involving IRAK1,
IRAK4 and TRAF6. Activated TRAF6 can interact with the
regulatory components of the nuclear receptor subfamily 2, group
C, member 2 (NR2C2) complex (also called the TGF-b activated
kinase [TAK1] complex), culminating in the activation of TAK1,
which can phosphorylate downstream targets, such as the IkB
kinases (IKKs). Phosphorylation of the IKK complex catalyses the
degradation of the NF-kB inhibitors (IKBs) resulting in the release
of the NF-kB complex, which translocates to the nucleus and
directs the transcription of many immune-related genes, including
inflammatory cytokines and chemokines necessary to prime the
adaptive immune response [54,55].
A MyD88-independent pathway (also called the TRIF-depen-
dent pathway) has also been reported as an alternative signalling
route for TLR4 and as the primary route for the membrane-
associated cytosolic TLR3 receptor. MyD88-independent signal-
ling involves the recruitment of at least two adaptor proteins:
TICAM1 (also called TRIF) and TICAM2 (also called TRAM).
TICAM1 can activate TRAF3 to induce interferon regulatory
factor 3 (IRF3)-mediated transcription of type I interferons (IFN),
or it can form heterodimeric signalling complexes with the
TNFRSF1A-associated via death domain (TRADD) and ralA
binding protein 1 (RALBP1, also called RIP1) proteins that induce
both NF-kB- and mitogen-activated protein kinases (MAPK)-
mediated transcription of inflammatory cytokines [54,55].
In the current study, inspection of the differentially expressed
genes at the 2 hour time point confirm a role for TLR-mediated
recognition of M. bovis in the challenged MDM. The only
differentially expressed TLR gene at this time point was TLR2
(upregulated), while many of the genes encoding proteins involved
in TLR signalling were also shown to be differentially expressed in
the M. bovis-challenged MDM at this time point. These included
MYD88 (downregulated); IRAK4 (downregulated); IRAK1 (down-
regulated); TICAM1 (upregulated); TRAF6 (upregulated); TRAF3
(upregulated); TAB2 (upregulated) and NFKBIA (upregulated).
TAB3 and NR2C2 were not differentially expressed.
The induction of TLR2 2 hours post-challenge suggest that this
PRR is involved in the early macrophage recognition of M. bovis.
However, the suppression of the genes encoding the MyD88
adaptor and the IRAK4 and IRAK1 kinases at this time point
post-challenge suggests that MyD88-dependent signalling is
repressed during M. bovis infection. Alternatively, these results
may point to the activation of a macrophage TLR2-dependent/
MyD88-independent signalling pathway involving alternative
adaptor protein(s), such as TICAM1, during M. bovis-challenge
in vitro. Furthermore, the increased relative expression of TRAF6
and TAB2 2 hours post-infection suggests that this signalling
cascade bypasses TRADD (the gene encoding TRADD was
downregulated) and RALBP1 (the gene encoding RALBP1 was
downregulated) and is relayed directly to the IKKs, inducing NF-
kB-directed transcription. Although there is little published work
on TLR2-dependent/MyD88-independent pathway(s), previous
research involving in vitro infections of murine peritoneal
macrophages with heat-killed M. tuberculosis was shown to result
in the expression of the secretory leukocyte peptidase inhibitor
gene (SLPI) via a TLR2-dependent/MyD88-independent pathway
[56]. Similarly, microarray-based analysis of the murine bone
marrow-derived macrophage transcriptome following infection
with virulent M. tuberculosis in vitro was also shown to induce
MyD88-independent signalling pathways, possibly involving
TLR2 [57].
The repression of MyD88-dependent signalling may represent a
transcriptional signature of M. bovis-mediated subversion of host
immune responses. Indeed, inhibition of IFN-c-induced MHC
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shown to involve MyD88-dependent signalling mediated through
TLR2 [58,59]. Thus, the suppression of TLR2-MyD88-dependent
signalling may represent one mechanism for immuno-evasion by
the mycobacterial pathogen enabling persistence within the host
macrophage during infection. In contrast, the activation of
MyD88-independent signalling may present an alternative route
used by host macrophages to circumvent suppressed MyD88-
dependent signalling and induce downstream transcription factors
which promote chemokine and cytokine production during
infection.
It is also important to note that as this is a transcriptomics study,
the functional role of various pre-existing TLR adaptor proteins in
macrophage cellular pathways during M. bovis infection cannot be
assessed at the RNA level; consequently, their involvement in these
pathways cannot be fully excluded. Further work involving both
transcriptomic and proteomic platforms is required to investigate
fully a role for macrophage TLR2-dependent/MyD88-indepen-
dent signalling pathways in response to mycobacterial infection.
A role for intracellular PRR-signalling in the control of M.
bovis infection in vitro
Inspection of the list of differentially expressed genes demon-
strated that the expression of several genes encoding intracellular
PRRs_which are generally associated with the detection of viral
PAMPs, such as viral RNA_is modulated during M. bovis challenge
in vitro. This was further supported by systems analysis, which
identified Signalling by RIG-I-like receptors in anti-viral innate immunity
and Activation of interferon regulatory factors by cytosolic pattern recognitions
receptors among the top ranking canonical pathways at 6 hours and
24 hours post-M. bovis challenge, respectively.
RIG-I-like receptors (RLRs) represent a group of RNA helicases
that function as cytosolic sensors of PAMPs within viral RNA or
processed self RNA ligands to elicit innate immune responses to
control infection. To-date, three RLR protein members have been
identified: retinoic acid-inducible gene I (RIG-I, encoded by
DDX58); melanoma differentiation associated factor 5 (MDA5,
encoded by IFIH1); and laboratory of genetics and physiology 2
and a homolog of mouse D11lgp2 (LPG2, encoded by DHX58)
[60]. In general, intracellular signalling mediated by RLRs results
in the activation of downstream transcription factors that
culminates in the production of type I IFN and antiviral proteins
that control viral infection [60]. Notably, all three genes were
differentially expressed in the current study at the 6 hour and
24 hour time points: DDX58 (downregulated at 6 hours and
upregulated at 24 hours), IFIH1 (upregulated at 6 hours and
24 hours) and DHX58 (upregulated at 24 hours).
Genes encoding members of the TLR3 signalling pathway also
displayed differential expression in the M. bovis-challenged MDM
at the 6 hour and 24 hour time points. TLR3 encodes a
membrane-bound intracellular PRR that localises to endosomes
and is involved in the recognition of viral PAMPs, such as double-
stranded reoviral RNA [54]. TLR3-mediated signalling occurs
through the TICAM1 adaptor which recruits TRAF3 to activate
IRF3-mediated transcription of type I IFN. In the current study,
TLR3 was upregulated in the M. bovis-challenged MDM samples at
6 hours and 24 hours post-challenge, while upregulation of
TRAF3, IRF3 and INFB1 was also observed at the 24 hour time
point. TICAM1 was not differentially expressed at either the
6 hour or 24 hour time points.
The involvement of RLRs and TLR3 in mediating the
macrophage response to M. bovis infection is intriguing given their
well-documented role in the detection of viral PAMPs. However,
transfection experiments have shown that murine bone marrow-
derived macrophage production of type I IFN in response to RNA
isolated from Legionella pneumophila (a gram-negative bacterium that
replicates in host macrophages and causes severe pneumonia) is
mediated via RIG-I [61]; while RNA from Helicobacter pylori (a
gram positive bacterium that causes gastritis) was also shown to
induce type I IFN production via a RIG-I-mediated signalling
pathway in mouse dendritic cells [62]. Moreover, increased TLR3
RNA and protein expression has been reported in human
leukocytes following in vitro stimulation with bacterial lipopolysac-
charide (LPS), while increased relative TLR3 expression has been
reported by us in the transcriptome of peripheral blood leukocytes
(PBL) from cattle displaying active BTB compared to the PBL
transcriptome of non-infected control animals [48,62].
Collectively, these findings support a role for cytosolic RLRs
and TLR3 during host infection with intracellular bacterial
pathogens. It has been proposed that activation of intracellular
PRRs by bacterial PAMPs is due to the translocation of bacterial
RNA into host cells, or is a consequence of the generation of host-
derived RNA ligands caused by the pathogen-mediated disruption
of host cellular pathways during infection [61]. Another possibility
is that intracellular PRRs mediate autophagy in infected
macrophages, which is increasingly regarded as a key anti-
mycobacterial host defence mechanism [63–65]. Autophagy is a
complex cellular process in which host cell cytosolic components,
such as damaged or surplus organelles, are engulfed in double-
membrane vesicles called autophagosomes and fused with late
endosomes or lysosomes to degrade their contents. However,
further work is required to investigate a role for RLR- and TLR3-
mediated autophagy in response to mycobacterial infection.
Pro- and anti-apoptotic global transcriptional signatures
associated with M. bovis challenge in vitro
Systems analysis of the differentially expressed genes revealed
significant enrichment for genes involved in programmed cell
death (apoptosis), particularly at 6 hours post-M. bovis challenge.
Apoptosis is a complex biological process triggered by the
engagement of protein receptors and ligands that initiate a
caspase-directed signalling cascade. In particular, caspase activa-
tion and subsequent apoptosis is elicited upon the binding of TNF-
a and the Fas ligand protein (FASLG) to their respective cell
surface receptors, TNF-R1 or TNF-R2 and the FAS (TNF
receptor superfamily member 6) receptor. This interaction results
in the initiation of a death-inducing signal complex that involves
recruitment of FADD, caspase 8 (CASP8) and CASP10, triggering
a signalling cascade that culminates in the activation of effector
caspases (such as CASP3, CASP6 and CASP7) and other non-
caspase enzymes that induce DNA fragmentation, mitochondrial
membrane permeability and degradation, and apoptotic vesicle
formation [66].
In the current study, genes encoding members of the caspase
family of proteins together with several pro- and anti-apoptotic
mediators were differentially expressed following challenge with
M. bovis. TNF was among the pro-apoptotic genes displaying
upregulated gene expression in the M. bovis-challenged MDM at
the 6 hour time point; however, the gene encoding the pro-
apoptotic TNF-R1 receptor (TNFRSF1A) was downregulated at
this time point. In contrast, the gene encoding the pro-apoptotic
FAS (TNF receptor superfamily member 6) receptor (FAS) was
upregulated in these MDM samples.
FADD and the death-domain associated protein gene (DAXX),
which encode adaptor proteins that mediate pro-apoptotic signals
from activated TNF-R1 [67] and the FAS receptor [68],
respectively, were also upregulated after 6 hours post-challenge.
Induction of the BH3 interacting domain death agonist gene (BID)
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truncated BID (tBID), forms heterodimeric complexes with other
pro-apoptotic proteins causing mitochondrial membrane perme-
ability and the release of cytochrome C, which activates the
effector caspases to induce apoptosis [66].
Several anti-apoptotic genes also exhibited differential expres-
sion at the 6 hour time point. These included the gene encoding
TNF-R2 (TNFRSF1B) [upregulated] that recruits the encoded
product of the apoptosis inhibitor baculoviral IAP repeat
containing 3 gene (BIRC3; downregulated) [69]. Notably,
expression of the B-cell CLL/lymphoma 2 gene (BCL2) that
encodes a protein that inhibits mitochondrial membrane perme-
ability and prevents apoptosis [70] was suppressed following M.
bovis challenge in vitro at this time point.
Macrophage apoptosis is increasingly regarded as a host innate
immune mechanism in controlling mycobacterial infection by
containing and limiting mycobacterial growth [71]. Recently,
microarray-based studies of mycobacterial infection of bovine
macrophages in vitro revealed over-representation of genes
associated with apoptosis among the list of differentially expressed
genes [14,15]. The detection of apoptotic signatures of gene
expression here supports this earlier work and indicates that
apoptosis is an early response of host MDM to M. bovis infection.
Although analysis of the differentially expressed genes following
M. bovis-challenge largely supports induction of a pro-apoptotic
response in these cells, presumably to eliminate the intracellular
pathogen, the increased relative expression of several anti-
apoptotic genes suggests that this process is highly regulated.
Anti-apoptotic signals may represent a host mechanism to limit the
amount of cell death following infection and may also enable
improved antigen-presentation by infected macrophages to T cells,
resulting in either elimination of the pathogen or enhanced
granuloma formation. It is also possible that the pro- and anti-
apoptotic signals detected here represent transcriptional signatures
of ‘‘bystander’’ apoptosis, whereby uninfected macrophages
undergo apoptosis following contact with mycobacteria-infected
macrophages [15,72].
Alternatively, the induction of anti-apoptotic genes may signify
an immuno-subversion mechanism used by the pathogen that
postpones apoptosis and enables survival and replication within
the macrophage [10]. Indeed, recent studies have shown that
virulent M. tuberculosis can subvert host apoptotic pathways by
interfering with the production of key host signalling molecules
[71,73], resulting in the arrest of apoptosis and induction of
necrosis, thereby offering an exit route from the macrophage [10].
Therefore, induction of anti-apoptotic genes as identified by the
current study may provide another strategy used by the pathogen
for the evasion of the host immune system.
Induction of chemokine and cytokine genes following M.
bovis-challenge
The innate immune response to mycobacterial pathogens is
largely mediated by immuno-regulatory cytokines and chemokines
secreted by various immune cells that regulate the recruitment and
expansion of immune cell populations, such as monocytes,
neutrophils, T cells and other effector cells from the blood to the
site of infection [74]. Macrophage production of cytokines and
chemokines in response to mycobacterial infection can be induced
through a wide range of PRR-mediated pathways, and their
secretion primes the adaptive immune response, which is pivotal in
determining pathogenesis [75].
In the current study, several inflammatory chemokine and
cytokine genes were shown to display large increases in relative
expression following M. bovis-challenge across all of the time points
analysed, with systems analysis showing that many of the top
ranking GO categories were enriched for large numbers of these
genes (see Tables S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11, and
S12). These results confirm that cytokine and chemokine gene
expression is an early response of bovine macrophages to M. bovis-
challenge following pathogen recognition by PRRs [14,76].
Many of the upregulated inflammatory genes detected here
have been shown to play an important role in the immune
response to mycobacterial infection and several of these direct the
transition from innate to adaptive immunity during infection [3].
Indeed, the GO categories identified via systems analysis of the
differentially expressed genes here suggest that the expression of
macrophage genes involved in the communication between innate
and adaptive immune cell types is a key biological process that
occurs within the first 24 hours of M. bovis challenge in vitro. For
example, TNF-a is a key pleiotropic cytokine produced by
macrophages that plays an important role in granuloma formation
and maintenance by inducing IFN-c release from T cells, which in
turn, activates anti-mycobacterial function in infected macrophag-
es [4,77]. IL12 (upregulated at all three time points) encodes a pro-
inflammatory cytokine produced by macrophages that activates
NK cells and T cells to produce IFN-c and promote the adaptive
immune response to mycobacterial infection [78]. IL-1b (encoded
by IL1B, upregulated all time points) is a proinflammatory
cytokine secreted largely by innate immune cells in response to
mycobacterial infection and studies have shown that IL-1b is
produced in excess at the site of infection, suggesting that it plays
an important role in granuloma formation and maintenance [79].
Genes encoding b-chemokines (such as CCL20, which was
upregulated at all three time points) participate in early
immuno-protection against mycobacterial pathogens following
infection [80,81].
IL-6, a pleiotropic inflammatory cytokine expressed by a wide
range of immune cells including macrophages in response to
mycobacterial infection, has been proposed to play an important
role in protection against tuberculosis [82]. IL6 displayed large
fold-upregulation at all three time points analysed in the M. bovis-
challenged MDM, while the gene encoding the IL-6 receptor
(IL6R) displayed downregulation expression in the M. bovis-
challenged MDM at 2 hours and 24 hours and was not
differentially expressed at the 6 hour time point. This suggests
that endogenous IL-6 production by macrophages acts in an
endocrine manner, presumably by initiating immune responses in
other innate or adaptive immune cells [83]. Indeed, IL-6 has been
proposed as a key regulator of the immunological switch between
innate and adaptive immune processes [84].
Despite the role of chemokines and cytokines in directing the
host immune response to control mycobacterial infection, there is
evidence to suggest that their function can be used by
mycobacterial pathogens to enable persistence within the host.
For example, non-regulated production of TNF-a in lung tissue
can result in immunopathology, including destructive inflamma-
tion and necrosis, allowing dissemination of the pathogen from
infected cells [11,85]. Furthermore, studies have shown that IL-6
can inhibit T cell responses following infection of macrophages
with M. bovis-BCG and M. avium subspecies paratuberculosis [86],
while other investigations have reported that M. tuberculosis-
induced IL-6 production inhibits the anti-microbial activity of
macrophages in response to IFN-c [87]. IL10, which encodes an
anti-inflammatory cytokine that limits local cytokine-induced
tissue damage and systemic inflammatory responses during
infection [88], was upregulated at 2 hours and 24 hours post-
challenge. Interestingly, upregulation of IL10 resulting in the
subsequent suppression of host innate immune responses to
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enhanced mycobacterial intracellular proliferation [89]. Thus,
exploitation of the roles of key pro- and anti-inflammatory
cytokines may enable M. bovis to evade elimination by the host
adaptive immune response, enabling disease progression.
Conclusions
In the current study, we have analysed the bovine macrophage
transcriptome in response to M. bovis-challenge in vitro using a
global microarray platform. Inspection and systems analysis of the
differentially expressed genes identified several key cellular
pathways involved in the host response to M. bovis, including
TLR and RLR signalling and apoptosis. These transcriptional
signatures highlight the complex interactions between host
macrophages and the mycobacterial pathogen during infection.
Further analyses involving the comparison of gene expression
changes in bovine macrophages to other mycobacterial species,
such as M. bovis-BCG and M. avium subspecies paratuberculosis, may
also highlight the differential responses of the host macrophage to
these pathogens and enable identification of key cellular pathways
that contribute to the development of pathology. Furthermore, the
identification of gene expression patterns linked to infection and
pathology could provide a route to improved BTB diagnostics.
Supporting Information
Figure S1 Regression analysis of relative gene expres-
sion fold-changes in the M. bovis-challenged MDM
obtained from real time qRT-PCR analysis using
conventionally-prepared and linearly amplified cDNA.
Log2 fold-changes in gene expression in the M. bovis-challenged
MDM relative to the control MDM were plotted. Data obtained
from the conventionally-prepared cDNA are plotted on the y-axis,
while data obtained for the linearly amplified cDNA prepared
using the WT-Ovation
TM RNA Amplification System (OVA) are
plotted on the x-axis. The P-value of the slope for all regression
lines was#0.001. Graph construction and analyses were per-
formed using the Minitab version 16 software package. S=stan-
dard deviation; R-Sq=r
2 value.
(TIF)
Figure S2 Comparison of the fold-changes in expression
for the CCL5, CCL20, IL1B and IL6 genes based on real
time qRT-PCR analysis using conventional and linearly
amplified cDNA. Log2 fold-changes in expression in the M.
bovis-challenged MDM relative to the control MDM at all three
time points are shown. Linearly amplified cDNA template (OVA)
was prepared using the WT-Ovation
TM RNA Amplification
System. For comparison, the expression profiles for these genes
as per the microarray data are also shown. The significance of the
fold-changes in expression for each gene based on the real time
qRT-PCR analysis only are denoted by asterisks in the figure
(*P#0.05, **P#0.01, ***P#0.001). The fold-changes calculated
for each gene the microarray data in the M. bovis-challenged
MDM for each gene were significant (adjusted P-value#0.05). In
addition, the log2 fold-change in expression for the control MDM
at each time point relative to the 0 hour control MDM are also
shown for both the microarray and real time qRT-PCR data; no
significant differences in gene expression between the control
MDM relative to the 0 hour control was observed at each time
point (P$0.05).
(PDF)
Figure S3 Real time qRT-PCR analysis. Log2 fold-changes
in expression in the M. bovis-challenged MDM relative to the
control MDM at all three time points are shown. For comparison,
the expression profiles for these genes as per the microarray data
are also shown. The significance of the mean fold-changes in
expression for each gene based on the real time qRT-PCR analysis
only are denoted by asterisks in the figure (*P#0.05, **P#0.01,
***P#0.001). The mean fold-changes calculated for each gene
based on the microarray data in the M. bovis-challenged MDM for
each gene were significant (adjusted P-value#0.05)_probes for
TICAM1 were not present on the microarray and this gene was
analysed by real time qRT-PCR only. In addition, the log2 fold-
change in expression for the control MDM at each time point
relative to the 0 hour control MDM are also shown for both the
microarray and real time qRT-PCR data; no significant
differences in gene expression between the control MDM relative
to the 0 hour control was observed at each time point (P$0.05).
(PDF)
Table S1 Real time qRT-PCR primers used in this
study.
(DOC)
Table S2 The list of differentially expressed transcripts
detected at the 2 hour time point post-M. bovis chal-
lenge.
(XLS)
Table S3 Gene ontology (GO) categories identified
using IPA at the 2 hour time point post-M. bovis
challenge. The top ranking GO categories identified by IPA
are listed according to P-values.
(XLS)
Table S4 Top-ranking canonical pathways identified
using IPA at the 2 hour time point post-M. bovis
challenge. The top ranking canonical pathways identified by
IPA are listed according to P-values. The ratio indicates the
number of differentially expressed genes involved in each
canonical pathway divided by the total number of genes within
each pathway as per the IPA Knowledge Base.
(XLS)
Table S5 The list of differentially expressed transcripts
detected at the 6 hour time point post-M. bovis chal-
lenge.
(XLS)
Table S6 Gene ontology (GO) categories identified
using IPA at the 6 hour time point post-M. bovis
challenge. The top ranking GO categories identified by IPA
are listed according to P-values.
(XLS)
Table S7 Top-ranking canonical pathways identified
using IPA at the 6 hour time point post-M. bovis
challenge. The top ranking canonical pathways identified by
IPA are listed according to P-values. The ratio indicates the
number of differentially expressed genes involved in each
canonical pathway divided by the total number of genes within
each pathway according to the IPA Knowledge Base.
(XLS)
Table S8 The list of differentially expressed transcripts
detected at the 24 hour time point post-M. bovis
challenge.
(XLS)
Table S9 Gene ontology (GO) categories identified
using IPA at the 24 hour time point post-M. bovis
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PLoS ONE | www.plosone.org 15 February 2012 | Volume 7 | Issue 2 | e32034challenge. The top ranking GO categories identified by IPA are
listed according to P-values.
(XLS)
Table S10 Top-ranking canonical pathways identified
using IPA at the 24 hour time point post-M. bovis
challenge. The top ranking canonical pathways identified by
IPA are listed according to P-values. The ratio indicates the
number of differentially expressed genes involved in each
canonical pathway divided by the total number of genes within
each pathway according to the IPA Knowledge Base.
(XLS)
Table S11 Comparison of relative gene expression fold-
changes in the M. bovis-challenged MDM obtained from
real time qRT-PCR analysis using conventionally-pre-
pared and linearly amplified cDNA. Geometric mean fold-
changes in gene expression (M. bovis-challenged MDM versus
control MDM) are given. P-values were obtained by statistical
analysis of log2 fold-change gene expression data.
(DOC)
Table S12 Comparison of fold-changes in gene expres-
sion in the M. bovis-challenged MDM based on micro-
array and real time qRT-PCR results. Geometric mean
fold-changes of gene expression (M. bovis-challenged MDM
relative to control MDM) are given for the microarray and real
time qRT-PCR data at each time point. All genes at each time
point were significantly differentially expressed based on the
microarray data (adjusted P-value#0.05). The P-values obtained
from analysis of the real time qRT-PCR analysis are presented.
Descriptions of the function of each gene were obtained from the
GeneCards version 3 database [90]. ‘Not DE’ indicates that the
gene was note differentially expressed according to the real time
qRT-PCR data.
(DOC)
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